ATE260672T1 - Pharmazeutische lysin enthaltende polypeptid- zusammensetzungen und verfahren zu deren verwendung - Google Patents

Pharmazeutische lysin enthaltende polypeptid- zusammensetzungen und verfahren zu deren verwendung

Info

Publication number: ATE260672T1
Authority: AT; Austria
Prior art keywords: methods; compositions containing; glx; polypeptide compositions; containing lysine
Prior art date: 1991-10-28

Application number

AT92923065T

Other languages

English (en)

Inventor

Lawrence R Green

Vadim T Ivanov

Inessa I Mikhalyova

Boris V Vaskovsky

Alexander N Mikhaltsov

Vladimir K Khavinson

Vyacheslav G Morozov

Original Assignee

Cytran Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-10-28

Filing date

1992-10-28

Publication date

2004-03-15

1992-10-28 Application filed by Cytran Ltd filed Critical Cytran Ltd

2004-03-15 Application granted granted Critical

2004-03-15 Publication of ATE260672T1 publication Critical patent/ATE260672T1/de

Links

238000000034 method Methods 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 title 1
239000004472 Lysine Substances 0.000 title 1
229920001184 polypeptide Polymers 0.000 title 1
208000001388 Opportunistic Infections Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Ophthalmology & Optometry (AREA)
Pulmonology (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Urology & Nephrology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AT92923065T 1991-10-28 1992-10-28 Pharmazeutische lysin enthaltende polypeptid- zusammensetzungen und verfahren zu deren verwendung ATE260672T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US78351791A	1991-10-28	1991-10-28
PCT/US1992/009252 WO1993008816A1 (en)	1991-10-28	1992-10-28	Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof

Publications (1)

Publication Number	Publication Date
ATE260672T1 true ATE260672T1 (de)	2004-03-15

Family

ID=25129521

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92923065T ATE260672T1 (de)	1991-10-28	1992-10-28	Pharmazeutische lysin enthaltende polypeptid- zusammensetzungen und verfahren zu deren verwendung

Country Status (10)

Country	Link
EP (1)	EP0613375B1 (de)
JP (1)	JPH07503705A (de)
KR (1)	KR100266929B1 (de)
AT (1)	ATE260672T1 (de)
AU (1)	AU665789B2 (de)
CA (1)	CA2122024A1 (de)
DE (1)	DE69233315T2 (de)
DK (1)	DK0613375T3 (de)
ES (1)	ES2217255T3 (de)
WO (1)	WO1993008816A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5807830A (en) *	1987-12-30	1998-09-15	Cytoven J.V.	Method for treatment of purulent inflammatory diseases
US6066622A (en)	1991-10-28	2000-05-23	Cytran, Inc.	Immunomodulating peptides and methods of use
WO1993012810A1 (en) *	1992-01-02	1993-07-08	Cytoven	Pharmaceutical pentapeptide compositions and methods of use thereof
WO1995003067A1 (en) *	1993-07-21	1995-02-02	Khavinson Vladimir Khatskelevi	Pharmaceutical with immunomodulating activity
US7868206B2 (en)	2005-12-27	2011-01-11	National University Corporation, Gunma University	Trihalomethionine derivative and pharmaceutical product containing the same
US20170260235A1 (en) *	2010-04-27	2017-09-14	Chanel Parfums Beaute	Polypeptide expressed in the stratum corneum and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1363801A (en) *	1971-03-26	1974-08-21	Merck & Co Inc	Peptides and their preparation
US4395404A (en) *	1982-05-14	1983-07-26	George Washington University	Synthetic thymosin β3 and β4 analogues
DE3421614A1 (de) *	1984-06-09	1985-12-12	Hoechst Ag, 6230 Frankfurt	Verfahren zur herstellung von pentapeptiden mit wirkung auf das immunsystem und zwischenprodukte dieses verfahrens

1992
- 1992-10-28 KR KR1019940701386A patent/KR100266929B1/ko not_active Expired - Fee Related
- 1992-10-28 AU AU29155/92A patent/AU665789B2/en not_active Ceased
- 1992-10-28 JP JP5508573A patent/JPH07503705A/ja not_active Ceased
- 1992-10-28 AT AT92923065T patent/ATE260672T1/de not_active IP Right Cessation
- 1992-10-28 WO PCT/US1992/009252 patent/WO1993008816A1/en not_active Ceased
- 1992-10-28 DE DE69233315T patent/DE69233315T2/de not_active Expired - Fee Related
- 1992-10-28 DK DK92923065T patent/DK0613375T3/da active
- 1992-10-28 CA CA002122024A patent/CA2122024A1/en not_active Abandoned
- 1992-10-28 ES ES92923065T patent/ES2217255T3/es not_active Expired - Lifetime
- 1992-10-28 EP EP92923065A patent/EP0613375B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE69233315D1 (de)	2004-04-08
DE69233315T2 (de)	2005-03-31
AU2915592A (en)	1993-06-07
HK1013622A1 (en)	1999-09-03
EP0613375A4 (de)	1996-08-07
KR100266929B1 (ko)	2000-09-15
AU665789B2 (en)	1996-01-18
CA2122024A1 (en)	1993-05-13
WO1993008816A1 (en)	1993-05-13
EP0613375B1 (de)	2004-03-03
EP0613375A1 (de)	1994-09-07
ES2217255T3 (es)	2004-11-01
JPH07503705A (ja)	1995-04-20
DK0613375T3 (da)	2004-07-12

Similar Documents

Publication	Publication Date	Title
ATE188219T1 (de)	2000-01-15	Pharmazeutische dipeptid zusammensetzungen und verwendungsmethoden.
DE59102210D1 (de)	1994-08-25	Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
RU95107881A (ru)	1996-11-27	Фармацевтическая композиция для лечения аллергических заболеваний, способ антигистаминного лечения, применение композиции для получения лекарственного препарата
BG101118A (en)	1998-04-30	Therapeutical compounds
ATE211384T1 (de)	2002-01-15	Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
ATE257704T1 (de)	2004-01-15	Pharmazeutische zusammensetzungen enthaltend norastemizol.
ZA899796B (en)	1990-08-29	Therapeutically active substituted benzimidazole and process for its preparation
BR9814498A (pt)	2000-10-10	Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
EG19302A (en)	1994-11-30	Compound with gastric acid inhibitory effect and process for its preparation
ATE260672T1 (de)	2004-03-15	Pharmazeutische lysin enthaltende polypeptid- zusammensetzungen und verfahren zu deren verwendung
DK347289A (da)	1990-01-15	Terapeutiske forbindelser
NO810480L (no)	1981-08-14	Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
ATE205829T1 (de)	2001-10-15	Fibrinogen receptor antagonisten mit substituierten b-aminosäurenestern und diese enthaltende pharmazeutische präparate
RU94040865A (ru)	1996-08-10	Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью
EP0621789A4 (en)	1995-09-06	Pharmaceutical pentapeptide compositions and methods of use thereof.
EP0257418A3 (en)	1989-12-20	Oxirane-pseudo-oligosaccharides, process for their synthesis, their use and pharmaceutical preparations
DE3777411D1 (de)	1992-04-16	Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.
IT1248669B (it)	1995-01-26	Derivato di idrossiprolina, sua preparazione e composizioni farmaceutiche che lo contengono
SE9003040D0 (sv)	1990-09-25	Analogues of cyclolinopeptide a and the use thereof
RU92016559A (ru)	1996-10-27	Производные диалкокси-пиридинилбензимидазола, фармацевтическая композиция, способ ингибирования или лечения, способ их получения, применение и промежуточные соединения
MY110416A (en)	1998-05-30	Composition for the treatment of schizophrenia.
IT1255268B (it)	1995-10-25	Composizione farmaceutica ad attivita' antitosse

Legal Events

Date

Code

Title

Description

2004-12-15

UEP

Publication of translation of european patent specification

Ref document number: 0613375

Country of ref document: EP

2008-07-15

REN

Ceased due to non-payment of the annual fee